About this trial
DFNA9 (Deafness Autosomal Dominant 9) is an autosomal dominant hereditary hearing loss which is associated with vestibular deterioration. The most recent genotype-phenotype correlation studies have been conducted more than 15 years ago. Meanwhile, emerging and valuable vestibular tests have been added to the vestibular test battery. These tests were not available at the time of the correlation studies. The aim of this study is to carry out a prospective cross-sectional study on symptomatic and presymptomatic affected carriers of the Pro51Ser (P51S) Coagulation Factor C Homology (COCH) mutation in order to correlate vestibular data using the complete vestibular test battery with the known data on hearing and vestibular function in relation to age.
Eligibility criteria
Qualifiers
subject must be 18 year of older
subject is a family member of the family pedigree's proband(s) carrying a P51S COCH mutation
Disqualifiers
subject is younger than 18 years
subject is not a family member of the pedigree's proband(s) carrying a P51S
subject cannot undergo investigations (medical and/or mental reasons)
subject is not willing to be enrolled into the study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Jessa Hospital
Lead sponsor
University Hospital, Antwerp
Collaborator
Maastricht University Medical Center
Collaborator